A study to evaluate treatment patterns and investigate adult patients with B-cell lymphoma - Clarity-BR

This is a retrospective observational registry study designed to characterise patient profiles, assess treatment patterns, evaluate clinical outcomes and explore COO testing patterns among adult patients with newly diagnosed LDGCB who have not previously received treatment (TN) and are receiving first-line (1L) treatment.

This is a retrospective observational registry study designed to characterise patient profiles, assess treatment patterns, evaluate clinical outcomes and explore COO testing patterns among adult patients with newly diagnosed LDGCB who have not previously received treatment (TN) and are receiving first-line (1L) treatment. Patients who commenced first-line systemic treatment during the study identification period, from 1 January 2020 to one year prior to the end of the study period (which will vary according to the data source), will be eligible for inclusion in the study. Data will be collected, analysed and summarised separately for each participating country. In Brazil, the study will use data available from the Study’s Local Database – Einstein Hospital Israelita, including patient demographic data such as age and gender; clinical information such as diagnosis, disease stage, details of the patient’s general condition and laboratory test results; and information on treatment.